These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2660958)

  • 21. Double-blind study of a new nonionic contrast agent for cardiac angiography.
    Reagan K; Bettman MA; Finkelstein J; Ganz P; Grassi CJ
    Radiology; 1988 May; 167(2):409-13. PubMed ID: 3282261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative trial of the diagnostic quality of and tolerance for two concentrations of ioxaglate when used for phlebography.
    Thomas ML; Bowles JN; Treweeke PS; Turnbull P
    J Can Assoc Radiol; 1985 Sep; 36(3):209-11. PubMed ID: 3900079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroangiography with iohexol.
    Bryan RN; Miller SL; Roehm JO; Weatherall PT
    AJNR Am J Neuroradiol; 1983; 4(3):344-6. PubMed ID: 6410740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iohexol in phlebography of the leg. A comparative investigation with meglumine metrizoate.
    Gjølberg T; Andrew E; Enge I
    Invest Radiol; 1985; 20(1 Suppl):S103-7. PubMed ID: 3882611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iohexol and iopromide--two new non-ionic water-soluble radiographic contrast media: randomized, intraindividual double-blind study versus ioxaglate in peripheral angiography.
    Hagen B
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():107-14. PubMed ID: 6139064
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (Optiray).
    Le Mignon MM; Azau C; Arthaud A; Bonnemain B
    Eur J Radiol; 1991; 13(2):126-33. PubMed ID: 1743190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of contrast media in cerebral angiography: iopamidol vs. methylglucamine iothalamate.
    Bird CR; Drayer BP; Velaj R; Triolo PJ; Allen S; Bates M; Yeates AE; Heinz ER; Osborne DR
    AJNR Am J Neuroradiol; 1984; 5(6):801-3. PubMed ID: 6437183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iohexol cerebral angiography. Multicenter clinical trial.
    Kido DK; Potts DG; Bryan RN; Norman D; Pelz DM; Fox AJ; Shaw DD
    Invest Radiol; 1985; 20(1 Suppl):S55-7. PubMed ID: 3882617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of Iohexol vs. Conray 60 for cerebral angiography.
    Pelz D; Fox AJ; Viñuela F
    AJNR Am J Neuroradiol; 1984; 5(5):565-8. PubMed ID: 6435421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult peripheral angiography. Results from four North American randomized clinical trials of ionic media versus iohexol.
    Wolf GL
    Acta Radiol Suppl; 1983; 366():166-70. PubMed ID: 6382932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis following phlebography with high-osmolar and low-osmolar contrast media.
    Eliasen B; Hørup A; Jensen AR
    Eur J Radiol; 1983 May; 3(2):97-8. PubMed ID: 6347689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and efficacy of Hexabrix in cerebral angiography.
    Norman D; Brant-Zawadzki M; Sobel D
    Invest Radiol; 1984; 19(6 Suppl):S306-7. PubMed ID: 6392158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double blind clinical study comparing the safety, tolerance and efficacy of ioversol 240 and iohexol 240 (Omnipaque 240) in ascending venography.
    Wilkins RA; Spinks BC
    Clin Radiol; 1990 Apr; 41(4):268-71. PubMed ID: 2187651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iohexol in patients with previous adverse reactions to contrast media.
    Holtås S
    Invest Radiol; 1984; 19(6):563-5. PubMed ID: 6511264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical testing of iohexol, conray meglumine and amipaque in cerebral angiography.
    Ingstrup HM; Hauge P
    Neuroradiology; 1982; 23(2):75-9. PubMed ID: 7043304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol-300 in cerebral angiography.
    Ringel K; Kuehn J
    Invest Radiol; 1989 Jun; 24 Suppl 1():S48-51. PubMed ID: 2687196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early hemodynamic reactions of an ionic low osmolar and a nonionic contrast medium].
    Wink K; Heinrich R
    Z Kardiol; 1984 Oct; 73(10):628-33. PubMed ID: 6516515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hexabrix as a contrast agent for ascending leg phlebography.
    Murphy WA; Destouet JM; Gilula LA; Monsees B; Reinus WR; Totty WG
    AJR Am J Roentgenol; 1985 Jun; 144(6):1279-81. PubMed ID: 3873813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of iohexol and meglumine iothalamate in double-contrast knee arthrography.
    Belli A; Renton P; Stoker DJ
    Clin Radiol; 1984 Sep; 35(5):375-7. PubMed ID: 6380886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and pharmacokinetics of ioversol in healthy volunteers.
    Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
    Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.